Editorials & Perspectives absence of a specific GPI-anchored protein? At the level of cell biology, do PNH clones persist for decades, and how does a single clone sustain virtually all hematopoietic activity? At the cellular level, what is the fate of all the proteins that are destined to be GPI-anchored but produced in an anchorless environment-are they degraded, digested, secreted or shed from the cell, and with what consequences? For what reason has evolution preserved the GPI-anchor for certain proteins? Indeed, we have little information on the biophysical differences and the functional consequences that result from a GPI-anchor attachment compared to the more conventional transmembrane configuration. GPIanchored proteins attach via a "fatty foot" to the surface but do not extend internally beyond the cell's membrane; they associate in cholesterol-rich, detergentinsoluble lipid raft structures and presumably must cooperate with other proteins in order to convey an internal signal after engaging a ligand.
Paroxysmal nocturnal hemoglobinuria and bone marrow failurePerhaps the major focus of current research in PNH is the relationship of PNH and marrow failure in patients and the associated basic problem of PNH clonal expansion. Clinically, PNH has a strong relationship with aplastic anemia. Historically, some patients were recognized to have a mixture of the two diseases, manifesting both marrow failure and intravascular hemolysis. Many patients with PNH have low blood counts that cannot be attributed to peripheral destruction of cells and many younger PNH patients develop aplastic anemia. In patients first diagnosed with acquired aplastic anemia, PNH sometimes appeared to evolve after immunosuppressive treatment.The replacement of the cumbersome Ham test with flow cytometric assays for GPI-anchored proteins greatly simplified and quantified diagnostic testing for PNH, and also allowed a better description of the relationship between PNH and aplastic anemia. By flow cytometry investigation of granulocytes, expanded clones of PNH cells were observed in a large proportion of patients with aplastic anemia at the time of their presentation; if they recovered, the clone was apparent also in erythrocytes, having been obscured earlier by transfused blood cells. As described above, minute numbers of PNH granulocytes are present in normal individuals. At the time of diagnosis of aplastic anemia, between one third and one half of cases have elevated numbers of PNH granulocytes, but the proportion is usually much lower -just a small percentage of the total neutrophils -than in classical hemolytic PNH, in which the proportion of erythrocytes and granulocytes that lack GPI-anchored proteins is high, usually above 50%. In aplastic anemia the small clone may be stable in size for years, and in only a minority of cases does it increase to levels associated with frank hemolysis and anemia.
The problem of clonal expansionThe PIG-A mutation alone is necessary but insufficient to explain PNH clonal expansion. In humans, PIG-A mu...